We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urges Sponsors to Conduct PK Studies to Show BA/BE
FDA Urges Sponsors to Conduct PK Studies to Show BA/BE
The FDA is asking sponsors of INDs, NDAs and NDA supplements to submit bioavailability and bioequivalency data from pharmacokinetic studies of their products.